| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | Change.org | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $61.44M | New Series A | 9/20/2018 | $61.44M | $96.9M | $0.21 | Undisclosed Investors | ||||
 | Chroma Medicine | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $262M | Series B | 3/1/2023 | $135M | $450.56M | $2.60 | ARCH Venture Partners, DCVC Bio, Mubadala Capital, Sixth Street, Alexandria Venture Investments, Atlas Venture, Casdin Vapital, Cormorant Asset Management, Janus Henderson Investors, Newpath Partners, Omega Funds, Osage University Partners, Sofinnova Partners, T Rowe Price, Wellington Management | ||||
 | Clearbit | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $35.2M | Series A-5 | 6/17/2022 | $15M | $277.77M | $11.60 | Undisclosed Investors | ||||
 | ClearMotion | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $117.88M | Series B+ | 9/30/2024 | $15.8M | $297.88M | $0.25 | Undisclosed Investors | ||||
 | Coast | Fintech Fintech Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $131.67M | Series B-3 | 6/9/2026 | $35M | $366.41M | $22.53 | Undisclosed Investors | ||||
 | CREXi | Real Estate Real Estate Software | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | $444.04K | -- | 2 | Not available | -- | -- | $112.85M | Series B | 3/29/2022 | $40M | $491.16M | $8.56 | Brightstone Venture Capital, FJ Labs | ||||
 | Curative | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $8.79M | Series A-7 | 9/23/2020 | $2.86M | $37.8M | $0.04 | DCVC, Refactor Capital, Chris Anderson | ||||
 | Detect | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $77.02M | Series A-1 | 7/29/2026 | $31.99M | $118.22M | $1.22 | Undisclosed Investors | ||||
 | Ditto | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $136.7M | Series B | 3/12/2025 | $82.7M | $469.27M | $13.64 | Top Tier Capital Partners, Acrew Capital, U.S. Innovative Technology Fund, True Ventures, Amity Ventures, Fundrise, Friends & Family Capital, Advance Venture Partners, Internet Initiative Japan | ||||
 | Duetto | Consumer & Lifestyle Consumer & Lifestyle Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $117.68M | Series D | 2/14/2018 | $80M | $249.91M | $4.79 | Warburg Pincus, H14, Expanding Capital | ||||
 | End Game Interactive | Consumer & Lifestyle Gaming | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $55.56M | Series B | 1/28/2022 | $34.78M | $255.96M | $13.06 | Undisclosed Investors | ||||
 | Entire | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $60M | Series Seed | 2/10/2026 | $60M | $300M | $25.92 | Felicis, Madrona, M12, Basis Set Ventures, 20VC, Cherry Ventures, Picus Capital, Global Founders Capital, Gergely Orosz, Theo Browne, Jerry Yang, Olivier Pomel, Garry Tan, Harry Stebbings | ||||
 | Evommune | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $268.46M | Series C | 10/31/2024 | $115.5M | $346.35M | $1.59 | RA Capital Management, Sectoral Asset Management, B Capital, Marshall Wace, Avego Bioscience Capital, Longwood Fund, RTW Investments, ADAR1 Capital Management, NEXTBio Capital, Beiersdorf Venture Capital, FemHealth Ventures, Allostery Investments LP, Pivotal bioVenture Partners, EQT Life Sciences, Andera Partners, Amplitude Ventures, SymBiosis, Verition Fund Management | ||||
 | FINESSE | Consumer & Lifestyle Clothing, Fashion, Beauty & Apparel | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $56.38M | Series A-1 | 7/1/2023 | $40M | $300.43M | $17.12 | TQ Ventures, Cherry Ventures, MaC Venture Capital, Hoxton Ventures, Mango Capital | ||||
 | Flare Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $290.35M | Series C | 6/30/2026 | $85M | $188.49M | $0.37 | Third Rock Ventures, Nextech Invest, Pfizer, Boxer Capital, GordonMD Global Investments, Invus, Casdin Capital, Eli Lilly and Company, Novartis, Agent Capital, Eventide Asset Management | ||||
 | FreeWill | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $42.45M | Series B | 3/2/2022 | $30M | $323.64M | $25.03 | Bain Capital, ICONIQ Growth, QED Investors, Ulu, Highland, Pear, HearstLab | ||||
 | Genalyte | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $30.23M | Series 1 | 1/30/2026 | $30.23M | $58.16M | $0.38 | Undisclosed Investors | ||||
 | Geneoscopy | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $163.58M | Series C | 1/8/2025 | $79.05M | $447.85M | $4.13 | Bio-Rad Laboratories, Petrichor, Labcorp, Morningside Ventures, Lightchain Capital, NT Investments, Granger Management, Mercy Health, Tri Locum Partners | ||||
 | Globality | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $691.7M | Series D-2 | 10/22/2024 | $15.21M | $107.94M | $0.63 | Rollins Capital | ||||
 | Guidewheel | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $52.59M | Series B | 8/13/2024 | $5.97M | $112.52M | $2.63 | Decarbonization Partners, Ecolab, Rethink Impact, GSBackers, Greycroft, Breakthrough Energy Ventures | ||||
 | HALO Precision Diagnostics | Healthcare Medical Devices | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $173.71M | Series C-2 | 4/11/2025 | $27.95M | $293.85M | $0.81 | Undisclosed Investors | ||||
 | Handle | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $75.49M | Series B | 5/5/2026 | $27M | $266.19M | $15.49 | Marbruck Investments, Energize Capital, Suffolk Technologies, Liquid 2 Ventures, RXR ARDEN Digital Ventures, WEX | ||||
 | Harmonic | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $30M | Series A-1 | 11/6/2022 | $19.97M | $235.56M | $17.85 | Sozo Ventures, Craft Ventures, Alumni Ventures, Soma Capital, Teamworthy Ventures, Builders VC, Fin Venture Capital, Flexport, Sam Parr, Pelion Venture Partners, Shasta Ventures, MVP Ventures, NNS | ||||
 | HealthSherpa | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $9.37M | Series A-1 | 9/17/2018 | $2.62M | $54.27M | $3.94 | Undisclosed Investors | ||||